-
Mashup Score: 2Aligned Blog: Celebrating Native American Heritage Month: in conversation with Karina Walters, Ph.D., M.S.W. - 2 hour(s) ago
To celebrate Native American Heritage Month, we spoke with Karina Walters, Ph.D., M.S.W., Director of the NIH Tribal Research Health Office (THRO). Dr. Walters, an enrolled member of the Choctaw Nation of Oklahoma, shares what motivates her in working to improve the lives of Indigenous People, her vision for THRO and her own experience as a researcher.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Aligned Blog: Celebrating Native American Heritage Month: in conversation with Karina Walters, Ph.D., M.S.W. - 6 hour(s) ago
To celebrate Native American Heritage Month, we spoke with Karina Walters, Ph.D., M.S.W., Director of the NIH Tribal Research Health Office (THRO). Dr. Walters, an enrolled member of the Choctaw Nation of Oklahoma, shares what motivates her in working to improve the lives of Indigenous People, her vision for THRO and her own experience as a researcher.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
In honor of #NativeAmericanHeritageMonth, we are sharing a conversation with Dr. Karina Walters, who directs @NIHs Tribal Research Health Office (THRO). She spoke about efforts to improve the lives of indigenous peoples and her vision for THRO. https://t.co/rRvaWiDHZp https://t.co/XaHy62on1i
-
-
Mashup Score: 1Removing risk of stomach cancer for her daughter - 14 day(s) ago
Stomach cancer remains deadly in the United States despite its rarity. After discovering she was at high risk for the disease, Estefania E. Marchan decided to undergo a total gastrectomy. For a subsequent pregnancy, she ensured her daughter would never face the same risks.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
After discovering she was at high risk for #StomachCancer, Estefania Marchan underwent surgery to remove her stomach. Two years later, she gave birth to her daughter via IVF pregnancy. Read Estefania's story from 2022. https://t.co/Wt80PWyxFC
-
-
Mashup Score: 18First clinical trial testing a prevention for breast cancer metastasis to the brain yields encouraging results - 29 day(s) ago
When breast cancer metastasizes to the brain, new tumors usually develop even after treatment. But recurrence was low among women who received low-dose temozolomide with T-DM1 in a phase I clinical trial.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
A #ClinicalTrial testing a drug combination designed to prevent metastatic tumors from recurring in the brains of women with advanced #BreastCancer yielded encouraging results in 2023. Learn more. https://t.co/3CAMfMT9OR
-
-
Mashup Score: 2
CCR researchers have discovered that certain immune cells in the liver, called MAITs, often surround liver tumors but fail to infiltrate them. An analysis suggests that treatment with immune checkpoint inhibitors could potentially trigger these immune cells to help them infiltrate and attack the tumors.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
NCI researchers recently identified a type of immune cell in the liver that might be helpful for treating cancer. Read about mucosal-associated invariant T (MAIT) cells: https://t.co/0qP8e6Bj18 #LiverCancer #LCAM #immunotherapy
-
-
Mashup Score: 8Patient Resources for Hereditary Diffuse Gastric Cancer - 1 month(s) ago
Download PDF We know that there are a lot of things to consider from the moment you think you may have hereditary diffuse gastric cancer, so we’ve collected patient resources for you to use every step of the way. If you have questions or suggestions for additional resources, please email foregut@mail.nih.gov.
Source: ccr.cancer.govCategories: General Medicine News, Hem/OncsTweet-
Patient Resources for Hereditary Diffuse Gastric Cancer https://t.co/CxsnTj6G03 For patients, their families, and practitioners looking for guidance. #CDH1 #HDGC #CTNNA1 @StomachCancer_ @StoCANcer @feedthecure @NoStomach4Cancr
-
-
Mashup Score: 9For Patients - 1 month(s) ago
About Our TrialsThe Liver Cancer Program (LCP) conducts clinical trials for patients with many different types of liver cancer, including hepatocellular carcinoma (the most common type of primary liver cancer) and cholangiocarcinoma (cancer that begins in the bile ducts). The NCI CLARITY study is a national collaborative network study on immunotherapy for liver cancer. You can see a complete list of our current clinical trials here.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
WATCH: Dr. Cecilia Monge is a physician in the #LiverCancer program in NCI's Center for Cancer Research’s. In this video, Dr. Monge talks about what patients can expect when they become involved in a clinical trial. Learn more in English & Español. https://t.co/Pq16d6Mh8t #LCAM https://t.co/gicyRieg5G
-
-
Mashup Score: 4Moxe for Leukemia - 2 month(s) ago
The U.S. Food and Drug Administration’s (FDA) approval of moxetumomab pasudotox (Lumoxiti) in September 2018 for certain adults with hairy cell leukemia (HCL) provides a promising new therapy to a group of patients who previously had few other options. It also marks the latest milestone in a decades-long journey that unfolded largely in CCR.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
Hairy cell leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Learn more about the development of a treatment for this rare type of #leukemia. https://t.co/XnLmlFlqUX #CancelBloodCancer https://t.co/f5ukUUCwkY
-
-
Mashup Score: 4
This year’s U.S. Food and Drug Administration’s 4th Annual National Black Family Cancer Awareness Week falls from June 13-19, 2024. In honor of the theme, “Engaging Generations,” we invited Michaela Taylor, M.S., CGC, Cancer Genetics Counselor in the Genetics Branch to write about the value of genetic counseling for Black and African American people and how broaching this sometimes difficult topic can lead to empowerment.
Source: ccr.cancer.govCategories: General Medicine News, Oncologists1Tweet-
On NCI’s Aligned Blog, Michaela Taylor, M.S., an NCI Cancer Genetic Counselor, wrote recently about the value of genetic counseling for Black and African American people and how broaching this sometimes-difficult topic can lead to empowerment. https://t.co/BlbTjxTtFr #BRCAAware
-
-
Mashup Score: 16
Welcome to the National Cancer Institute (NCI), Prostate Cancer Multidisciplinary Clinic (PCMC). Our clinic began in September 2008 as a service to the NCI community. Since then we have expanded our care to include any patients with biopsy-proven prostate cancer. The clinic is federally funded. There is no cost to those receiving care at the NIH Clinical Center. Our clinic is designed to provide the prostate cancer patient with a comprehensive consultation visit to discuss their diagnosis and treatment
Source: ccr.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Have you been diagnosed with #ProstateCancer and are you looking for a group of specialists to give you more information or a second opinion? Learn more about how NCI can come alongside you and help. https://t.co/Q2PX3d7t4N
-
In honor of #NativeAmericanHeritageMonth, we are sharing a conversation with Dr. Karina Walters, who directs @NIHs Tribal Research Health Office (THRO). She spoke about efforts to improve the lives of indigenous peoples and her vision for THRO. https://t.co/rRvaWiDHZp https://t.co/XaHy62on1i